Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis.

PubWeight™: 2.78‹?› | Rank: Top 1%

🔗 View Article (PMC 3425353)

Published in Nature on March 28, 2010

Authors

Ling Zhang1, Xiaoyang Ren, Eckhard Alt, Xiaowen Bai, Shaoyi Huang, Zhengming Xu, Patrick M Lynch, Mary P Moyer, Xian-Feng Wen, Xiangwei Wu

Author Affiliations

1: Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

Articles citing this

Cells of origin in cancer. Nature (2011) 6.85

Retinoids regulate stem cell differentiation. J Cell Physiol (2011) 1.91

Tumor promotion via injury- and death-induced inflammation. Immunity (2011) 1.81

Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets (2011) 1.38

Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol Cell Proteomics (2013) 1.34

Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis. Proc Natl Acad Sci U S A (2010) 1.26

Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers (Basel) (2011) 1.25

c-FLIP, a master anti-apoptotic regulator. Exp Oncol (2012) 1.24

Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. Cancer Res (2012) 1.23

Adipose tissue-derived stem cells promote prostate tumor growth. Prostate (2010) 1.22

'Gut health': a new objective in medicine? BMC Med (2011) 1.15

Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics. Mol Syst Biol (2011) 1.11

Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells. PLoS One (2010) 1.08

Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells. J Cell Physiol (2013) 0.96

Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail. PLoS One (2013) 0.95

Design of "smart" probes for optical imaging of apoptosis. Am J Nucl Med Mol Imaging (2011) 0.94

An intermittent approach for cancer chemoprevention. Nat Rev Cancer (2011) 0.92

Molecular targets of TRAIL-sensitizing agents in colorectal cancer. Int J Mol Sci (2012) 0.91

Proteasomal regulation of caspase-8 in cancer cell apoptosis. Apoptosis (2013) 0.89

Molecular imaging of apoptosis: from micro to macro. Theranostics (2015) 0.86

Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86

Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects. Cell Death Dis (2013) 0.86

Targeted expression of tumor necrosis factor-related apoptosis-inducing ligand TRAIL in skin protects mice against chemical carcinogenesis. Mol Cancer (2011) 0.84

The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes. Subcell Biochem (2014) 0.83

Progress against cancer (1971-2011): how far have we come? J Intern Med (2011) 0.83

Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula. Evid Based Complement Alternat Med (2013) 0.82

The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition. Cancer Prev Res (Phila) (2012) 0.82

Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest. Biochem Pharmacol (2012) 0.81

Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression. EBioMedicine (2015) 0.81

TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame. Cancer Cell Int (2012) 0.81

Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol (2015) 0.81

BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A (2014) 0.80

Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol (2016) 0.80

Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach. Cancer Prev Res (Phila) (2011) 0.79

5-Fluorouracil preferentially sensitizes mutant KRAS non-small cell lung carcinoma cells to TRAIL-induced apoptosis. Mol Oncol (2015) 0.78

Senescence-secreted factors activate Myc and sensitize pretransformed cells to TRAIL-induced apoptosis. Aging Cell (2014) 0.78

6-OHDA-Induced Changes in Parkinson`s Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells. Cell Mol Neurobiol (2015) 0.78

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells. Oncotarget (2016) 0.76

Osteogenic cell differentiation on H-terminated and O-terminated nanocrystalline diamond films. Int J Nanomedicine (2015) 0.76

Colorectal cancer chemoprevention: the potential of a selective approach. Expert Rev Anticancer Ther (2010) 0.75

Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs. Curr Pharmacol Rep (2015) 0.75

American Ginseng Attenuates Colitis-Associated Colon Carcinogenesis in Mice: Impact on Gut Microbiota and Metabolomics. Cancer Prev Res (Phila) (2016) 0.75

Synthetic lethal interaction may be a new approach in chemoprevention of colorectal cancer. Gastroenterol Clin Biol (2010) 0.75

Turning off the BCL-2 switch to prevent intestinal tumorigenesis. Oncotarget (2016) 0.75

Dietary fat and fiber interactively modulate apoptosis and mitochondrial bioenergetic profiles in mouse colon in a site-specific manner. Eur J Cancer Prev (2016) 0.75

Adhesion and differentiation of Saos-2 osteoblast-like cells on chromium-doped diamond-like carbon coatings. J Mater Sci Mater Med (2016) 0.75

Articles cited by this

Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32

Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity (1995) 10.59

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (1992) 10.12

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (1990) 9.90

The many ways of Wnt in cancer. Curr Opin Genet Dev (2007) 6.29

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem (1996) 6.22

p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci U S A (1994) 5.49

A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell (2003) 3.90

Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy (2003) 3.58

Wnt signaling and stem cell control. Cell Res (2008) 3.53

A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A (1994) 3.33

Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc (1976) 3.19

Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov (2008) 2.95

Cell culture of human colon adenomas and carcinomas. Cancer Res (1987) 2.68

The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci (1992) 2.58

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med (2001) 2.41

Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc Natl Acad Sci U S A (2001) 2.00

Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol Cell Biol (2004) 1.90

The promise of TRAIL--potential and risks of a novel anticancer therapy. J Mol Med (Berl) (2007) 1.73

Electrophysiological properties of human adipose tissue-derived stem cells. Am J Physiol Cell Physiol (2007) 1.20

Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Cancer Res (2005) 1.15

A mouse model of human familial adenomatous polyposis. J Exp Zool (1997) 1.10

c-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis. EMBO J (2007) 1.08

Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Cancer Res (2000) 0.99

VEGF receptor Flk-1 plays an important role in c-kit expression in adipose tissue derived stem cells. FEBS Lett (2007) 0.88

Bypass NFkappaB-mediated survival pathways by TRAIL and Smac. Cancer Biol Ther (2007) 0.87

Solid tissues can be manipulated ex vivo and used as vehicles for gene therapy. J Gene Med (2005) 0.87

Articles by these authors

TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med (2009) 4.58

A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell (2003) 3.90

Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med (2012) 3.34

Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J (2007) 2.70

Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc (2007) 2.34

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev (2002) 2.31

Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev (2008) 2.22

Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J (2009) 2.21

NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13

Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer (2005) 2.04

Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer (2007) 1.82

IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst (2006) 1.70

Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet (2006) 1.59

Atrial mechanical performance after internal and external cardioversion of atrial fibrillation: an echocardiographic study. Chest (2002) 1.52

The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res (2002) 1.49

The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun (2007) 1.49

Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. Proc Natl Acad Sci U S A (2011) 1.48

Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol (2004) 1.43

MEK is a key modulator for TLR5-induced interleukin-8 and MIP3alpha gene expression in non-transformed human colonic epithelial cells. J Biol Chem (2004) 1.42

IFATS collection: Human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells (2009) 1.41

Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol (2005) 1.41

Percutaneous intraportal application of adipose tissue-derived mesenchymal stem cells using a balloon occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol (2013) 1.40

Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer. Int J Cancer (2008) 1.39

Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J Biol Chem (2004) 1.38

High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission. Anesth Analg (2016) 1.38

Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res (2003) 1.36

TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Nat Cell Biol (2010) 1.33

Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol Cell (2011) 1.31

gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect Immun (2008) 1.30

Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett (2009) 1.30

Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. J Biol Chem (2006) 1.27

Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol (2007) 1.26

Substance P mediates antiapoptotic responses in human colonocytes by Akt activation. Proc Natl Acad Sci U S A (2007) 1.25

Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology (2005) 1.25

Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Mol Nutr Food Res (2008) 1.24

Molecular screening for the Lynch syndrome--better than family history? N Engl J Med (2005) 1.22

CRISPR/Cas9-mediated targeted mutagenesis in Nicotiana tabacum. Plant Mol Biol (2014) 1.20

Electrophysiological properties of human adipose tissue-derived stem cells. Am J Physiol Cell Physiol (2007) 1.20

Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J Biol Chem (2005) 1.16

Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colonic cell growth. J Agric Food Chem (2004) 1.16

Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J Nutr Biochem (2007) 1.14

p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res (2004) 1.14

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.12

Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer (2012) 1.11

Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res (2009) 1.11

Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling. Mol Cancer Ther (2013) 1.10

Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging. Mol Imaging Biol (2011) 1.08

Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells. J Immunol (2006) 1.08

Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol (2003) 1.07

Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases. Biochem J (2002) 1.07

Peg3/Pw1 is a mediator between p53 and Bax in DNA damage-induced neuronal death. J Biol Chem (2002) 1.07

VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Commun (2007) 1.07

Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev (2008) 1.06

Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther (2005) 1.06

Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials (2008) 1.06

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res (2009) 1.05

Extracellular calcium sensing receptor stimulation in human colonic epithelial cells induces intracellular calcium oscillations and proliferation inhibition. J Cell Physiol (2010) 1.05

Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut (2007) 1.05

Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information. Genet Test (2005) 1.05

Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res (2010) 1.05

DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev (2006) 1.04

Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells. Adv Mater (2012) 1.02

Colorectal cancer screening. J Natl Compr Canc Netw (2013) 1.02

Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells. Biomaterials (2011) 1.02

LRP6 mediates cAMP generation by G protein-coupled receptors through regulating the membrane targeting of Gα(s). Sci Signal (2011) 1.02

Genetically selected stem cells from human adipose tissue express cardiac markers. Biochem Biophys Res Commun (2006) 1.02

Reliability and validity of the Repeatable Battery for the Assessment of Neuropsychological Status in community-dwelling elderly. Arch Med Sci (2011) 1.02

Noninvasive in vivo assessment of muscle impairment in the mdx mouse model--a comparison of two common wire hanging methods with two different results. J Neurosci Methods (2011) 1.00

Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot. Am J Hum Genet (2002) 1.00

Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis (2003) 1.00

Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem (2004) 1.00

Contribution of glutathione status to oxidant-induced mitochondrial DNA damage in colonic epithelial cells. Free Radic Biol Med (2009) 0.99

Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Anal Cell Pathol (Amst) (2010) 0.98

CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro. Cancer Lett (2009) 0.97

Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors. Theranostics (2012) 0.97

Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology (2005) 0.97

Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2006) 0.97

Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev (2004) 0.97

Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic contraction after fusion with neonatal rat cardiomyocytes. FASEB J (2010) 0.96

Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). J Natl Cancer Inst (2007) 0.95

Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol (2004) 0.95

Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. Mol Pharmacol (2005) 0.94

Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLoS One (2012) 0.94

Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Fam Cancer (2012) 0.93

Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells. Int J Cancer (2007) 0.93

Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cell Oncol (Dordr) (2011) 0.93

Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-kappaB pathway in human colonic epithelial cells. J Cell Biochem (2006) 0.92

Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer (2004) 0.92

Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control (2009) 0.92

Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis. Am J Pathol (2008) 0.92

Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem Biophys Res Commun (2010) 0.91

Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models. Cancer Lett (2012) 0.91